title: Comparative proteomic analysis reveals unique tumor protein composition among the melanoma subtypes pure desmoplastic and superficial spreading.
abstract: The U.S. death rate for melanoma has not decreased, despite the use of depth at biopsy and sentinel lymph node status to determine the risk of metastasis. Additional prognostic indicators and therapeutic targets are required, and identification of candidate proteins was the goal of this study. We utilized comparative mass spectrometry to compare five samples of each of two forms of melanoma, pure desmoplastic, which by depth at diagnosis has a favorable prognosis, and superficial spreading. Ontological analysis was applied to identify proteins and networks that were increased in one of the two subtypes. Analysis revealed a protein signature increase in pure desmoplastic melanoma associated with cell-to-cell binding and a signature increase in superficial spreading melanoma responsible for the cellular stress response including a constellation of heat shock proteins. The two subtypes of melanoma compared in this study have two unique protein compositions that correlate with their phenotypes. Further validation studies are warranted to evaluate the utility of identified proteins as prognostic markers and therapeutic targets.
authors.affiliation: Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
authors.forename: Michael K
authors.initials: MK
authors.lastname: Schowalter
authors.forename: Brittany O
authors.initials: BO
authors.lastname: Dulmage
authors.forename: Jonhan
authors.initials: J
authors.lastname: Ho
authors.forename: John R
authors.initials: JR
authors.lastname: Vu
authors.forename: Louis D
authors.initials: LD
authors.lastname: Falo
authors.forename: Larisa J
authors.initials: LJ
authors.lastname: Geskin
mesh_terms: D000328:Adult; D018572:Disease-Free Survival; D006801:Humans; D008545:Melanoma / Q000378:metabolism* / Q000473:pathology*; D009363:Neoplasm Proteins / Q000032:analysis / Q000378:metabolism*; D011379:Prognosis; D040901:Proteomics / Q000379:methods*; D012878:Skin Neoplasms / Q000378:metabolism* / Q000473:pathology*; D000096142:Cutaneous Malignant Melanoma
chemical_list: D009363:Neoplasm Proteins
references.citation: Ann Oncol. 2005;16 Suppl 1:i66-8
references.pmid: 15888761
references.citation: Am J Dermatopathol. 2012 Feb;34(1):82-90
references.pmid: 22197864
references.citation: Oncogene. 2001 Dec 6;20(56):8125-35
references.pmid: 11781826
references.citation: PLoS One. 2009;4(2):e4430
references.pmid: 19221597
references.citation: Cell Stress Chaperones. 2013 Mar;18(2):145-54
references.pmid: 22872370
references.citation: J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S17-25.e1-3
references.pmid: 22018063
references.citation: Oncogene. 2004 Jul 8;23(31):5330-9
references.pmid: 15064726
references.citation: Ann Surg Oncol. 2005 Mar;12(3):207-13
references.pmid: 15827812
references.citation: Br J Dermatol. 2013 Dec;169(6):1188-97
references.pmid: 23937674
references.citation: Epidemiology. 1990 Jan;1(1):43-6
references.pmid: 2081237
references.citation: J Proteome Res. 2008 Sep;7(9):4107-18
references.pmid: 18698805
references.citation: Cancer Res. 2003 Oct 15;63(20):6716-25
references.pmid: 14583466
references.citation: J Invest Dermatol. 2008 Dec;128(12):2905-8
references.pmid: 18615112